Coronavirus – Papula-Nevinpat continues to serve its clients as before

19.3.2020

Due to the coronavirus (COVID-19) pandemia, we want to inform all our clients and colleagues that Papula-Nevinpat continues to serve its clients as before.

We have taken measures to minimize possible effects caused by the coronavirus pandemia on our business, and plans exist to manage risks based on a wide range of scenarios. For example, all our employees are fully equipped for remote work. Therefore, we can confirm that we continue to operate without any disruption to our services.

You can be assured that we are closely following all announcements given by patent offices on any exceptional arrangements made in this crisis situation to ensure that all our clients’ IP rights will stay in force.

Papula-Nevinpat is taking every action to minimize the coronavirus infection risk and encourages each of its employees and colleagues to act in a responsible way. Our top priority is to safeguard the health and well-being of our employees, colleagues and others while also recognizing responsibility to our customers and the IP industry.

We closely monitor the pandemia situation and follow all guidelines issued by the Finnish institute for health and welfare, the Russian and Eurasian health authorities, and international organizations, such as WHO.

For any additional questions, please do not hesitate to contact us through our usual communication channels.

News

Helsinki head office closed for Ascension Day 13 May 2021

Kindly note that our Helsinki head office will be closed for Ascension Day on Thursday 13 May 2021 and will be fully operational again on Friday 14 May 2021.

Folke Johansson, Markku Simmelvuo and Marina Smirnova named as WIPR Leaders 2021

Papula-Nevinpat’s Folke Johansson, Markku Simmelvuo and Marina Smirnova have again been named as IP Leaders in the 2021 edition of World Intellectual Property Review’s WIPR Leaders.

How Halton uses IPR to keep fresh air flowing indoors

Halton has been providing indoor air solutions since the 1960s. With Papula-Nevinpat’s help, the company has built an IP and trademark portfolio for some of the world’s most advanced indoor air technology.

Patenting pharmaceuticals in Russia – what to know

The last episode in our spring 2021 Russia-Eurasia IP webinar series covered pharmaceutical patenting in Russia. The article includes the main points you should know.